Clinical Scorecard: Reassessing Fever in Sepsis: Is Mild Hyperthermia Beneficial?
At a Glance
Category
Detail
Condition
Fever in sepsis
Key Mechanisms
Fever is a regulated increase in hypothalamic temperature set point mediated by pyrogenic cytokines (IL-1, IL-6, TNF) and prostaglandin E2, enhancing innate and adaptive immune responses and inhibiting microbial growth.
Target Population
Patients with sepsis
Care Setting
Clinical settings managing sepsis, including intensive care units
Key Highlights
Fever stimulates immune functions including neutrophil release, natural killer cell activity, phagocytosis, antigen presentation, and lymphocyte migration.
Most mesophilic bacteria show growth inhibition at fever-range temperatures (38°C–41°C), coinciding with human fever.
Observational studies suggest that lowering temperature in septic patients may increase mortality, indicating potential benefits of mild hyperthermia.
Guideline-Based Recommendations
Diagnosis
Recognize fever as a regulated thermoregulatory response mediated by pyrogenic cytokines and prostaglandin E2.
Consider anatomical site and measurement device variability when assessing body temperature.
Management
Avoid indiscriminate antipyretic therapy in septic patients due to potential negative impact on outcomes.
Individualize temperature management in sepsis, balancing metabolic demands and immune benefits of fever.
Be cautious with temperature lowering in septic patients, especially avoiding hypothermia and high-grade fever extremes.
Monitoring & Follow-up
Monitor temperature trends carefully, noting fever phases (early peripheral and late central).
Assess for signs of shivering and increased metabolic demand when considering antipyretic therapy.
Risks
Recognize that both hypothermia and high-grade hyperthermia in sepsis are associated with adverse outcomes.
Consider increased metabolic rate and oxygen consumption as risks when fever is present, especially with shivering.
Patient & Prescribing Data
Adult and pediatric patients with sepsis
Antipyretic therapy is often used for patient comfort and metabolic considerations but may adversely affect immune response and outcomes in sepsis; pediatric use is often driven by fear of neurological complications.
Clinical Best Practices
Understand fever as an adaptive, evolutionarily conserved immune response rather than a harmful event.
Use temperature control strategies tailored to individual patient status and underlying cause of fever.
Recognize the immunomodulatory and antimicrobial benefits of fever-range temperatures in sepsis management.
